Cargando…
Identification of Novel Epitopes with Agonistic Activity for the Development of Tumor Immunotherapy Targeting TRAIL-R1
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-1/2 (TRAIL-R1/R2), also known as death receptors, are expressed in a wide variety of tumor cells. Although TRAIL can induce cell apoptosis by engaging its cognate TRAIL-R1/R2, some tumor cells are or become resistant to TRAIL t...
Autores principales: | Guo, Lu, Sun, Xin, Hao, Zhichao, Huang, Jingjing, Han, Xiaojian, You, Yajie, Li, Yaying, Shen, Meiying, Ozawa, Tatsuhiko, Kishi, Hiroyuki, Muraguchi, Atsushi, Jin, Aishun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595084/ https://www.ncbi.nlm.nih.gov/pubmed/28900492 http://dx.doi.org/10.7150/jca.19918 |
Ejemplares similares
-
Analysis of the clinical significance of DCLK1(+) colorectal cancer using novel monoclonal antibodies against DCLK1
por: Dai, Tianqi, et al.
Publicado: (2018) -
TRAIL-R1-Targeted CAR-T Cells Exhibit Dual Antitumor Efficacy
por: Nai, Yaru, et al.
Publicado: (2021) -
A Novel Rabbit Immunospot Array Assay on a Chip Allows for the Rapid Generation of Rabbit Monoclonal Antibodies with High Affinity
por: Ozawa, Tatsuhiko, et al.
Publicado: (2012) -
Evaluation of chimeric antigen receptor of humanized rabbit‐derived T cell receptor‐like antibody
por: Nakamura, Tomoko, et al.
Publicado: (2022) -
Unbiased Analysis of TCRα/β Chains at the Single-Cell Level in Human CD8(+) T-Cell Subsets
por: Sun, Xiaoming, et al.
Publicado: (2012)